Cargando…
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
The term epigenetics is defined as heritable changes in gene expression that are not due to alterations of the DNA sequence. In the last years, it has become more and more evident that dysregulated epigenetic regulatory processes have a central role in cancer onset and progression. In contrast to DN...
Autores principales: | Morera, Ludovica, Lübbert, Michael, Jung, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877953/ https://www.ncbi.nlm.nih.gov/pubmed/27222667 http://dx.doi.org/10.1186/s13148-016-0223-4 |
Ejemplares similares
-
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
por: Castelli, Germana, et al.
Publicado: (2017) -
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
por: Wagner, Julia M., et al.
Publicado: (2010) -
Histone methyltransferases and demethylases: regulators in balancing osteogenic and adipogenic differentiation of mesenchymal stem cells
por: Deng, Peng, et al.
Publicado: (2015) -
Crosstalk between epigenetics and metabolism—Yin and Yang of histone demethylases and methyltransferases in cancer
por: Filipp, Fabian V
Publicado: (2017) -
Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016)